Predictors of AoVC: univariate analysis | AoVC ≥1 | AoVC >61 | AoVC >454 | ||||||
---|---|---|---|---|---|---|---|---|---|
AoVC ≥1 | AoVC =0 | p | AoVC >61 | AoVC ≤61 | p | AoVC >450 | AoVC ≤454 | p | |
Male gender | 44 % | 40.7 % | 0.697 | 36 % | 46.2 % | 0.233 | 38.5 % | 43.3 % | 0.738 |
Dyslipidemia | 70.4 % | 84.9 % | 0.054 | 69.4 % | 62.7 % | 0.423 | 75 % | 64 % | 0.445 |
Diabetes | 26.5 % | 18.9 % | 0.292 | 22.4 % | 24.5 % | 0.781 | 16.7 % | 24.5 % | 0.543 |
Smoking | 12.2 % | 20.8 % | 0.165 | 8.2 % | 18.6 % | 0.094 | 8.3 % | 15.8 % | 0.488 |
Family history | 3.2 % | 5.9 % | 0.437 | 0 % | 6.3 % | 0.074 | 0 % | 4.5 % | 0.452 |
SBP (mmHg) | 149 ± 23 | 137 ± 23 | 0.003 | 148 ± 24 | 143 ± 23 | 0.248 | 155 ± 23 | 144 ± 24 | 0.105 |
DBP (mmHg) | 76 ± 13 | 80 ± 12 | 0.061 | 75 ± 12 | 78 ± 13 | 0.111 | 75 ± 14 | 77 ± 13 | 0.499 |
PP (mmHg) | 73 ± 22 | 58 ± 19 | <0.001 | 73 ± 21 | 65 ± 23 | 0.032 | 80 ± 26 | 67 ± 22 | 0.036 |
Age (years) | 66 ± 10 | 54 ± 12 | <0.001 | 71 ± 8 | 58 ± 12 | <0.001 | 74 ± 6 | 61 ± 12 | <0.001 |
Framingham | 15 ± 11 | 11 ± 11 | 0.003 | 14 ± 11 | 13 ± 11 | 0.231 | 17 ± 12 | 13 ± 11 | 0.127 |
SCORE | 3.1 ± 2.6 | 2.0 ± 2.2 | 0.001 | 3.2 ± 2.0 | 2.5 ± 2.7 | <0.001 | 4.1 ± 2.0 | 2.6 ± 2.6 | 0.002 |
GFR (mL/min/1.73 m2) | 86 ± 24 | 88 ± 20 | 0.560 | 83 ± 21 | 89 ± 23 | 0.131 | 78 ± 18 | 83 ± 23 | 0.176 |
CAC | 302 ± 745 | 96 ± 233 | <0.001 | 490 ± 994 | 102 ± 229 | <0.001 | 1014 ± 1571 | 156 ± 383 | 0.001 |
Calcified plaque | 72.3 % | 40.7 % | <0.001 | 82 % | 51.5 % | <0.001 | 92.3 % | 58.6 % | 0.017 |
Coronary Ather. | 72.7 % | 40.7 % | <0.001 | 72.7 % | 40.7 % | <0.001 | 69.2 % | 47.9 % | 0.140 |
Obstructive CAD | 29 % | 9.3 % | 0.005 | 44 % | 11.5 % | <0.001 | 53.8 % | 19.1 % | 0.004 |
Number of vessels with obstructive CAD | 0: 94.4 % | 0: 78 % | 0.031 | 0: 68 % | 0: 91.3 % | 0.001 | 0: 61.5 % | 0: 85.8 % | 0.007 |
1: 3.7 % | 1: 155 | 1: 22 % | 1: 5.8 % | 1: 15.4 % | 1: 10.6 % | ||||
>1: 1.9 % | >1: 7 % | >1: 10 % | >1: 2.9 % | >1: 23.1 % | >1: 3.5 % |